Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Author(s): Bevish Jinila* and Prayla S. Shyry

DOI: 10.2174/1574891X15666200915140806

DownloadDownload PDF Flyer Cite As
Transmissibility and Epidemicity of COVID-19 in India: A Case Study

Page: [79 - 85] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: The global outbreak of COVID-19 was first reported in Wuhan, China, in the late 2019. The origin of the infection is still unclear. Over time, it spread to 150 countries in the world, due to which, the World Health Organization (WHO) declared the infectious disease to be pandemic.

Objective: COVID-19 transmitted to India due to the arrival of travelers from other countries. The transmissibility and epidemicity of COVID-19 in India are exponential. So, in order to understand the above characteristics, specifically COVID-19 status in India has to be analyzed. To gain better insight on the matter, the state of Kerala is selected. The epidemiological characteristics of patients in Kerala, South India, and the possible transmission of COVID-19 from asymptomatic members to other peers are shown describing certain cases.

Methodology: The COVID-19 dataset is taken from the Kaggle dataset. This dataset contains the details of the infected patients from different states of India. Statistical analysis techniques were used to analyze the distribution of the affected cases in a particular state.

Case Presentation: The analysis shows that there is a possibility of the transmission of infection even during the incubation period. The recent trend in the number of infected cases in India is discussed.

Conclusion: The transmissibility of COVID-19 and its epidemicity in India are discussed. Specifically, a case study on COVID-19 cases in the state of Kerala relating transmissibility is also summarized. Further, data related to patents on coronavirus is also discussed. From the analysis, it can be concluded that there is a possibility of COVID-19 transmission even during the incubation period. The preventive measures to overcome COVID-19 and methods to increase immunity are discussed.

Keywords: COVID-19, incubation period, transmissibility, infection, epidemic, Kaggle dataset.

Graphical Abstract

[1]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020; 395(10223): 497-506.
[2]
Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020; 22(2): 69-71.
[http://dx.doi.org/10.1016/j.micinf.2020.01.004] [PMID: 32032682]
[3]
Linton M, Kobayashi T, Yang Y, et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data Journal. J Clin Med 2019; 9(2): 538.
[http://dx.doi.org/10.3390/jcm9020538]
[4]
Tian HY. 2019-nCoV: new challenges from coronavirus Chinese J Prev Med 2020; 54(0): E001.
[5]
Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill 2020; 25(5): 2000062.
[http://dx.doi.org/10.2807/1560-7917.ES.2020.25.5.2000062] [PMID: 32046819]
[6]
Stephen AL. Kyra HG, Qifang B, et al. The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application. Ann Intern Med 2020; 172(9): 577-82.
[7]
Yu P, Zhu J, Zhang Z, Han Y, Huang L. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis 2020; 221(11): 1757-61.
[http://dx.doi.org/10.1093/infdis/jiaa077]